AU691797B2 - Immunotherapeutic composition - Google Patents

Immunotherapeutic composition

Info

Publication number
AU691797B2
AU691797B2 AU59680/94A AU5968094A AU691797B2 AU 691797 B2 AU691797 B2 AU 691797B2 AU 59680/94 A AU59680/94 A AU 59680/94A AU 5968094 A AU5968094 A AU 5968094A AU 691797 B2 AU691797 B2 AU 691797B2
Authority
AU
Australia
Prior art keywords
cell wall
species
wall extract
mycobacterial cell
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU59680/94A
Other languages
English (en)
Other versions
AU5968094A (en
Inventor
Stanley J Alkemade
Graeme Mcrae
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vetrepharm Inc
Original Assignee
Vetrepharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vetrepharm Inc filed Critical Vetrepharm Inc
Publication of AU5968094A publication Critical patent/AU5968094A/en
Application granted granted Critical
Publication of AU691797B2 publication Critical patent/AU691797B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU59680/94A 1993-01-29 1994-01-28 Immunotherapeutic composition Expired AU691797B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1165593A 1993-01-29 1993-01-29
US011655 1993-01-29
PCT/CA1994/000054 WO1994016727A1 (fr) 1993-01-29 1994-01-28 Composition immunotherapeutique

Publications (2)

Publication Number Publication Date
AU5968094A AU5968094A (en) 1994-08-15
AU691797B2 true AU691797B2 (en) 1998-05-28

Family

ID=21751403

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59680/94A Expired AU691797B2 (en) 1993-01-29 1994-01-28 Immunotherapeutic composition

Country Status (11)

Country Link
US (1) US5759554A (fr)
EP (1) EP0681479B1 (fr)
JP (1) JPH08508976A (fr)
CN (1) CN1102855C (fr)
AT (1) ATE179333T1 (fr)
AU (1) AU691797B2 (fr)
BR (1) BR9406496A (fr)
DE (1) DE69418183T2 (fr)
DK (1) DK0681479T3 (fr)
NZ (1) NZ261094A (fr)
WO (1) WO1994016727A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO359396A0 (en) 1996-11-13 1996-12-05 Amrad Operations Pty. Limited A method of treatment and pharmaceutical compositions useful for same
CN1153574C (zh) * 1997-04-02 2004-06-16 比奥尼斯生命科学公司 细菌细胞壁提取物在制备预防,治疗或排除原生动物或寄生虫疾病的药物组合物上的应用
JP4335435B2 (ja) 1997-08-05 2009-09-30 バイオニケ ライフ サイエンシーズ インコーポレイテッド 細胞増殖および細胞死を調節する組成物および方法
PT1135164E (pt) * 1998-12-04 2004-11-30 Bioniche Life Sciences Inc Metodo para o tratamento de inflamacao
US6809081B1 (en) * 1998-12-04 2004-10-26 Bioniche Life Sciences, Inc. Chemotherapeutic composition and method
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
DE60033397T2 (de) * 1999-07-23 2007-05-31 Bioniche Life Science, Inc., Belleville Methode zur steigerung der produktionsleistung in tieren
US6890541B1 (en) 1999-07-23 2005-05-10 Bioniche Life Sciences, Inc. Method for enhancing production performance in an animal
CA2393808A1 (fr) * 1999-12-13 2001-06-21 Bioniche Life Sciences Inc. Oligonucleotides synthetiques anticancereux
DK1250152T3 (da) 1999-12-28 2013-08-26 Bioniche Urology Ip Inc Synergistisk sammensætning indeholdende hyaluronsyre til behandling af cancer
BR0109705A (pt) * 2000-03-31 2005-01-11 Idec Pharma Corp Uso combinado de anticorpos ou antagonistas anti-citocina e anticd20 para o tratamento de linfoma de célula b
JP5578390B2 (ja) * 2007-03-05 2014-08-27 株式会社 Ｍｂｒ 細菌細胞壁骨格成分の製造方法
US9044422B2 (en) * 2010-10-13 2015-06-02 Bioniche Urology Ip Inc. Bacterial ribonucleic acid cell wall compositions and methods of making and using them
TR201101874A2 (tr) 2011-02-25 2011-08-22 Leyla A�An Nac�Ye Yüzeyel mesane tümorü tedavisinde kullanılabilecek mycobacterıum(mikobakteri) brumae hücre duvarı ekstreleri.
EP3107566A4 (fr) * 2014-02-18 2017-10-11 Advaxis, Inc. Immunothérapie multi-cibles dirigée contre un biomarqueur
CA3015688A1 (fr) * 2016-02-25 2017-08-31 Thomas Julius Borody Compositions et procedes de traitement de maladies infectieuses chroniques
CN113244384A (zh) 2020-02-11 2021-08-13 阿尔特刚股份有限公司 抗病毒组合物
IT202000002866A1 (it) 2020-02-13 2021-08-13 Altergon Sa Composizioni antivirali
IT202000002641A1 (it) 2020-02-11 2021-08-11 Altergon Sa Composizioni antivirali
IT202100013292A1 (it) * 2021-05-21 2022-11-21 Aileens Pharma S R L Parete cellulare batterica legata a mucopolisaccaride suoi utilizzi e processo per la sua produzione

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3172815A (en) * 1962-04-24 1965-03-09 Warner Lambert Pharmaceutical Method for preparing reticulo-endo-thelial system stimulant and stimulant thereof
US3529057A (en) * 1964-08-14 1970-09-15 Takeda Chemical Industries Ltd Purified periodic acid-oxidized mucopeptide of mycobacteria cell walls constituting a vaccine enhancing nonspecific host resistance against pathogenic bacterial infections
US3331741A (en) * 1964-12-03 1967-07-18 Warner Lambert Pharmaceutical Process for the preparation of a soluble bacterial extract
FR2160326B1 (fr) * 1971-11-19 1975-02-07 Anvar
NL7308450A (fr) * 1972-06-20 1973-12-27
US4069314A (en) * 1973-02-23 1978-01-17 Christopher Adlam Glycopeptide extract
US4010257A (en) * 1973-02-23 1977-03-01 Burroughs Wellcome Co. Biological extracts
FR2269961B1 (fr) * 1974-05-06 1978-03-24 Anvar
FR2320107A1 (fr) * 1975-08-05 1977-03-04 Anvar Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant
US4340586A (en) * 1977-02-18 1982-07-20 Adam Bekierkunst Pharmaceutical preparation for treating disorders of the skin
US4504473A (en) * 1982-06-30 1985-03-12 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
US4505903A (en) * 1982-06-30 1985-03-19 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
US4503048A (en) * 1982-06-30 1985-03-05 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
FR2551758B1 (fr) * 1983-08-16 1986-01-31 Anvar Derives de muramyl-peptides et de steroides ayant des proprietes d'activation des macrophages
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
FR2662942B1 (fr) * 1990-06-06 1992-09-18 Neway Tsehay Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae.
DE69126668T2 (de) * 1990-11-08 1997-10-23 Univ London Mycobacterium als adjuvans für antigene

Also Published As

Publication number Publication date
DK0681479T3 (da) 1999-11-08
DE69418183T2 (de) 1999-12-16
NZ261094A (en) 1998-04-27
AU5968094A (en) 1994-08-15
EP0681479A1 (fr) 1995-11-15
DE69418183D1 (de) 1999-06-02
ATE179333T1 (de) 1999-05-15
US5759554A (en) 1998-06-02
EP0681479B1 (fr) 1999-04-28
BR9406496A (pt) 1996-01-02
WO1994016727A1 (fr) 1994-08-04
CN1102855C (zh) 2003-03-12
JPH08508976A (ja) 1996-09-24
CN1118574A (zh) 1996-03-13

Similar Documents

Publication Publication Date Title
AU691797B2 (en) Immunotherapeutic composition
CA1333152C (fr) Vaccin contenant des antigenes tumoraux et des adjuvants
AU665177B2 (en) Mycobacterium vaccae in the treatment of uveitis
US4744984A (en) Antiviral immunotherapeutic agent and preparation thereof
Tzianabos et al. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis.
JPH0564127B2 (fr)
CN1602199B (zh) 用于治疗包含免疫失调的疾病的革兰氏阳性菌制剂
US8425913B2 (en) Immunogenic agents against Burkholderia pseudomallei and/or Burkholderia mallei, comprising lipopolysaccharide, capsular polysaccharide and/or proteins from Burkholderia pseudomallei
KR20110100189A (ko) 백신 생산 방법
US9056073B2 (en) Vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias
CN101518549A (zh) 分枝杆菌提取物的研究和应用
US6503512B1 (en) Anti-AIDS immunomodulator complex
CA2154689C (fr) Composition immunotherapeutique amelioree
US4465665A (en) Detoxified E. coli neurotoxin, preparation thereof and immunological preparations containing it
Semel et al. Propionibacterium acnes-enhanced lens-induced granulomatous uveitis in the rat.
RU2468816C1 (ru) Пробиотический бактериальный препарат корпускулярных антигенов коринебактерий липопептидополисахаридной природы для профилактики и лечения туберкулеза, способ его получения
RU2080875C1 (ru) Способ получения поливалентной вакцины против кишечных инфекций
Bizzini et al. Experimental and Clinical Results
KR20160133087A (ko) 비활성화 바실러스 서브틸리스 스포아를 유효성분으로 포함하는 항암 백신 보조제
NZ197018A (en) Propionibacterium preparation(injectable)tumour treatment